NC trend: Chapel Hill drug development group seeks $200 million to combat next pandemic. - Business North Carolina
The Rapidly Emerging Antiviral Drug Development Initiative, or READDI, is tackling a monster challenge with a simple mission. “We’re trying to look into the future and create medicines against viruses we’ve never seen,” says CEO James Rosen. The nonprofit biotech company was launched in April 2020 by founding partners UNC Chapel Hill, the Structural Genomics […]| Business North Carolina
